JPWO2020001611A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020001611A5 JPWO2020001611A5 JP2020572815A JP2020572815A JPWO2020001611A5 JP WO2020001611 A5 JPWO2020001611 A5 JP WO2020001611A5 JP 2020572815 A JP2020572815 A JP 2020572815A JP 2020572815 A JP2020572815 A JP 2020572815A JP WO2020001611 A5 JPWO2020001611 A5 JP WO2020001611A5
- Authority
- JP
- Japan
- Prior art keywords
- diacid
- mannurone
- total weight
- pharmaceutical composition
- oligosaccharide composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 17
- 229920001542 oligosaccharide Polymers 0.000 claims 17
- 150000002482 oligosaccharides Chemical class 0.000 claims 17
- 239000008194 pharmaceutical composition Substances 0.000 claims 15
- 235000000346 sugar Nutrition 0.000 claims 7
- 239000002253 acid Substances 0.000 claims 4
- 150000008163 sugars Chemical class 0.000 claims 4
- 206010061218 Inflammation Diseases 0.000 claims 3
- 150000002016 disaccharides Chemical class 0.000 claims 3
- 230000004054 inflammatory process Effects 0.000 claims 3
- 238000006116 polymerization reaction Methods 0.000 claims 3
- 150000004044 tetrasaccharides Chemical class 0.000 claims 3
- 150000004043 trisaccharides Chemical class 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 2
- 201000004624 Dermatitis Diseases 0.000 claims 1
- 206010056340 Diabetic ulcer Diseases 0.000 claims 1
- 206010015150 Erythema Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 206010029240 Neuritis Diseases 0.000 claims 1
- 201000002661 Spondylitis Diseases 0.000 claims 1
- 208000035868 Vascular inflammations Diseases 0.000 claims 1
- 206010003246 arthritis Diseases 0.000 claims 1
- 231100000321 erythema Toxicity 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims 1
- 159000000000 sodium salts Chemical group 0.000 claims 1
- 230000009885 systemic effect Effects 0.000 claims 1
- 230000001256 tonic effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810721276.7A CN110652525A (zh) | 2018-06-29 | 2018-06-29 | 甘露糖醛二酸的组合物在治疗炎症中的应用 |
| CN201810721276.7 | 2018-06-29 | ||
| PCT/CN2019/093656 WO2020001611A1 (zh) | 2018-06-29 | 2019-06-28 | 甘露糖醛二酸的组合物在治疗炎症中的应用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021529195A JP2021529195A (ja) | 2021-10-28 |
| JPWO2020001611A5 true JPWO2020001611A5 (https=) | 2022-07-04 |
| JP2021529195A5 JP2021529195A5 (https=) | 2022-07-04 |
Family
ID=68985392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020572815A Pending JP2021529195A (ja) | 2018-06-29 | 2019-06-28 | 炎症の治療におけるマンヌロン二酸組成物の使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11406659B2 (https=) |
| EP (1) | EP3815693A4 (https=) |
| JP (1) | JP2021529195A (https=) |
| KR (1) | KR20210040041A (https=) |
| CN (1) | CN110652525A (https=) |
| AU (1) | AU2019296419A1 (https=) |
| WO (1) | WO2020001611A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112336742A (zh) * | 2019-08-06 | 2021-02-09 | 上海绿谷制药有限公司 | 甘露糖醛酸寡糖治疗Th1主导相关疾病的用途 |
| WO2025245773A1 (zh) * | 2024-05-30 | 2025-12-04 | 海糖（江苏）生物医药科技有限公司 | 一种褐藻寡糖衍生物及其制备方法和用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1562050A (zh) * | 2004-03-24 | 2005-01-12 | 中国海洋大学 | 褐藻酸寡糖在抗痴呆、抗糖尿病中的应用 |
| WO2007069468A1 (ja) * | 2005-12-14 | 2007-06-21 | Nagasaki University | サイトカイン分泌促進剤 |
| JP2016108474A (ja) * | 2014-12-08 | 2016-06-20 | 栄治 松村 | オリゴ糖の製造方法およびオリゴ糖 |
| CN106344592A (zh) | 2015-07-17 | 2017-01-25 | 上海绿谷制药有限公司 | 还原端1位为羧基的甘露糖醛酸寡糖及其衍生物在治疗帕金森氏症中的应用 |
| CN106344594A (zh) * | 2015-07-17 | 2017-01-25 | 上海绿谷制药有限公司 | 褐藻胶寡糖及其衍生物在治疗炎症中的应用 |
| CN106344595B (zh) | 2015-07-17 | 2020-06-19 | 上海绿谷制药有限公司 | 褐藻胶寡糖及其衍生物在制备治疗疼痛药物中的应用 |
| DE102016113018A1 (de) * | 2016-07-14 | 2018-01-18 | Abbas Mirshafiey | Pharmazeutische Verwendung von beta-D-Mannuronsäure |
| PL3498722T3 (pl) * | 2016-08-15 | 2021-09-20 | Shanghai Green Valley Pharmaceutical Co., Ltd. | Sposób przygotowania oligomerycznego dikwasu mannuronowego |
| JP6977059B2 (ja) * | 2016-12-30 | 2021-12-08 | シャンハイ、グリーン、バレー、ファーマスーティカル、カンパニー、リミテッドShanghai Green Valley Pharmaceutical Co., Ltd. | マンヌロン二酸の組成物 |
-
2018
- 2018-06-29 CN CN201810721276.7A patent/CN110652525A/zh active Pending
-
2019
- 2019-06-28 AU AU2019296419A patent/AU2019296419A1/en not_active Abandoned
- 2019-06-28 KR KR1020217001707A patent/KR20210040041A/ko not_active Ceased
- 2019-06-28 EP EP19825915.2A patent/EP3815693A4/en not_active Withdrawn
- 2019-06-28 WO PCT/CN2019/093656 patent/WO2020001611A1/zh not_active Ceased
- 2019-06-28 JP JP2020572815A patent/JP2021529195A/ja active Pending
- 2019-06-28 US US17/256,854 patent/US11406659B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024164167A5 (https=) | ||
| JP6214750B2 (ja) | 低用量トピラメート／フェンテルミン組成物およびその使用方法 | |
| US8653136B2 (en) | Compositions based on amino acids for improving the myocardial ventricular function in patients suffering from diabetes | |
| JP2008514647A5 (https=) | ||
| CN1111414C (zh) | 镁盐或镁配合物的制药用途 | |
| US10383894B2 (en) | Human medicinal treatment using salt of peroxymonosulfuric acid | |
| DK2034956T3 (en) | COMPOSITIONS INCLUDING LOW VISCOSY GLYCOSAMINOGLYCANES AND USING THE COMPOSITION FOR TREATING CHRONIC CYSTITIS | |
| CN1505505A (zh) | 辅酶q作为活性成分的经粘膜给药的组合物 | |
| KR101476802B1 (ko) | 염증성 장질환 치료 및 예방용 약학 조성물 | |
| JP2021529195A5 (https=) | ||
| DE202008006245U1 (de) | Zusammensetzung für die medizinische Anwendung, insbesondere Antazidum | |
| JPWO2020001611A5 (https=) | ||
| ES2356370T3 (es) | Preparaciones de uso externo para el tratamiento de la dermatitis. | |
| DE69705110T2 (de) | Topische pharmazeutische zusammensetzungen, welche heparin enthalten | |
| RU2005133665A (ru) | Применение производных 10-гидрокси-10,11-дигидрокарбамазепина для лечения аффективных расстройств | |
| JPWO2020001640A5 (https=) | ||
| JPWO2020001644A5 (https=) | ||
| JPWO2020001643A5 (https=) | ||
| JP2021528459A5 (https=) | ||
| JPWO2020123083A5 (https=) | ||
| JPWO2021119522A5 (https=) | ||
| ES2554332T3 (es) | Utilización de la bencidamina en el tratamiento de las enfermedades dependientes de p40 | |
| ALMEYDA et al. | Controlled trial of the treatment of atopic eczema with a urea‐hydrocortisone preparation versus betamethasone 17‐valerate | |
| CN111821295A (zh) | (5r)-5-羟基雷公藤内酯醇在制备治疗和/或预防皮肤炎症药物中的应用 | |
| EP1156830B1 (de) | Verwendung einer öl-in-wasser-emulsion zur herstellung eines arzneimittels |